Fennec Pharmaceuticals Inc.
USD10.80
-0.23 (-2.04%)
CEO
Jeffrey S. Hackman
IPO Date
2017-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.02
Prev. Close
$11.03
Day Low
$10.72
Day High
$11.21
52W Low
$5.65
52W High
$11.31
Market Cap
$0.31B
Volume
0.14M
| 20,000 |
| $8.70 |
| 10 Jun 2026 | Islam Khalid | director | A-Award | Acquired | 25,000 | $8.70 |
| 10 Jun 2026 | RALLIS CHRIS A | director | A-Award | Acquired | 20,000 | $8.70 |
| 2 Jun 2026 | Raykov Rosty | director | A-Award | Acquired | 2,778 | $0.00 |
| 2 Jun 2026 | Raykov Rosty | director | M-Exempt | Acquired | 15,597 | $2.45 |
| 2 Jun 2026 | Raykov Rosty | director | S-Sale | Disposed | 9,747 | $9.62 |
| 2 Jun 2026 | Raykov Rosty | director | M-Exempt | Disposed | 15,597 | $2.45 |
| 1 Jun 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A-Award | Acquired | 156 | $0.00 |
| 1 Jun 2026 | Evans Terry L | Chief Commercial Officer | A-Award | Acquired | 168 | $0.00 |